KRAS and neoplasm: Although previous study has reported that the microbiota can promote the progression of lung cancer induced by the Kras mutation and loss of p53 expression [17], the precise mechanism of its role in shaping the immune surveillance of tumour cells in Kras-driven lung cancer remains to be further explored.